Contrast-Enhanced EUS for Differential Diagnosis of Pancreatic Masses: A Meta-Analysis release_s2qpstpitzfu5a5cghr5hhzswq

by Sibin Mei, Mengyu Wang, Leimin Sun

Published in Gastroenterology Research and Practice by Hindawi Limited.

2019   Volume 2019, p1-9

Abstract

<jats:italic>Background</jats:italic>. Though methods for the diagnosis of pancreatic masses are various, such as ultrasonography (US), computed tomography (CT), endoscopic ultrasonography (EUS), and contrast-enhanced computed tomography (CE-CT), their sensitivity, specificity, and accuracy are not quite satisfying. Contrast-enhanced endoscopic ultrasonography (CE-EUS), as a new technique, has its own unique advantages in diagnosing pancreatic disease. However, its sensitivity, specificity, and accuracy are still controversial. <jats:italic>Objective</jats:italic>. To evaluate the accuracy of CE-EUS for differential diagnosis between benign and malignant pancreatic mass lesions. <jats:italic>Design</jats:italic>. Eighteen relevant articles systemically searched from PubMed, Web of Science, Ovid, Scopus, and MEDLINE were selected. The pooled results were calculated in a fixed effects model. <jats:italic>Main Outcome Measurement</jats:italic>. The pooled sensitivity, specificity, positive likelihood ratio (LR), negative likelihood ratio, diagnostic odds ratio (OR), and summary receiver operating characteristic (SROC) curve. <jats:italic>Results</jats:italic>. The pooled sensitivity, specificity, and diagnostic odds ratio of CE-EUS for the differential diagnosis of pancreatic adenocarcinomas were 0.91 (95% confidence interval (CI), 0.89-0.93), 0.86 (95% CI, 0.83-0.89), and 69.50 (95% CI, 48.89-98.80), respectively. The SROC area under the curve was 0.9545. The subgroup analysis based on excluding the outliers showed that the heterogeneity was eliminated and the pooled sensitivity and specificity were 0.92 (95% CI, 0.90-0.93) and 0.87 (95% CI, 0.84-0.89), respectively. The SROC area under the curve was 0.9569. <jats:italic>Conclusion</jats:italic>. CE-EUS is a useful method to distinguish pancreatic adenocarcinoma from other pancreatic diseases. Compared with EUS elastography, it has higher specificity. However, it is still not superior to pathological diagnosis for the identification of pancreatic carcinomas.
In application/xml+jats format

Archived Files and Locations

application/pdf  1.8 MB
file_cjuy36ze6zhrtclgmpzc2gr2eu
web.archive.org (webarchive)
downloads.hindawi.com (publisher)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2019-03-06
Language   en ?
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  1687-6121
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 1ae2aa60-5563-483e-9d7a-9c67304b4ddb
API URL: JSON